AVTX7:00 AMAvalo Therapeutics Reports First Quarter 2026 Financial Results and Recent Business UpdatesTrial Results • Phase 2Topline results Tue, May 5, 2026avalotx.com
AVTX4:01 PMAvalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis SuppurativaTrial Results • Phase 2avalotx.com